Clinical shorts

Kelsall, Diane
May 2011
CMAJ: Canadian Medical Association Journal;5/17/2011, Vol. 183 Issue 8, p933
Academic Journal
The article focuses on several clinical medicine studies. It mentions the CRASH-2 multicountry randomized trial which showed that early treatment with tranexamic acid greatly reduces the risk of death due to bleeding after a trauma. It presents a sham-controlled trial which revealed that anal injection of dextranomer in stabilized hyaluronic acid is effective against fecal incontinence. Furthermore, a study showed that prostate cancer screening may lead to overdetection and overtreatment.


Related Articles

  • Missing Possible Connections between Basic Research and Clinical Reality: Early Detection of Cancer as a Case In Point. Retsky, Michael // Journal of Bioequivalence & Bioavailability;2012, Vol. 4 Issue 7, p1 

    The author reflects on the issue concerning the association between basic research and clinical data in terms of early detection of cancer. The author cites a basic researcher who talked about his work using the TRAMP animal model of prostate cancer at a seminar. He notes that the researcher was...

  • Results bolster diagnostic value of PCa biomarker. Guttman, Cheryl // Urology Times;11/1/2008, Vol. 36 Issue 14, p14 

    The article reports on the findings of the studies regarding the prevalence of TMPRSS2-ERG gene fusion prostate cancer in men undergoing prostate biopsy in the U.S., and the performance of DNA methylation, and TMPRSS2-ERG gene fusion as prostate cancer biomarkers. One of the studies found that...

  • Viscosupplementation for Knee Osteoarthritis: A Systematic Review. Jon Divine // Clinical Orthopaedics & Related Research;Feb2007, Vol. 455 Issue 1, p113 

    Due to the rising number of patients affected by osteoarthritis (OA), appropriate management decisions for minimizing pain and improving physical function for patients with OA are important. Hyaluronic acid (HA) knee injections have become a common tool for the management of OA of the knee, and...

  • More than meets the eyes. Jesitus, John // Dermatology Times;Oct2012, Vol. 33 Issue 10, p60 

    The article offers the viewpoints of Dr. Joel L. Cohen, a dermatologist in private practice in Englewood, Colorado, on FDA-approved injectable neuromodulators, including onabotulinumtoxinA, abobotulinumtoxinA, and incobotulinumtoxinA, which, despite many similarities, are not interchangeable....

  • Measure PSA? Yes, it is cost-effective.  // Modern Medicine;Feb94, Vol. 62 Issue 2, p58 

    Presents an abstract on the editorial `Using prostate-specific antigen to diagnose prostate cancer: Sailing in uncharted waters,' by P.C. Walsh published in the November 1, 1993 issue of `Ann. Intern. Med.'

  • Controversial report says prostate screening is not worth the effort.  // Modern Medicine;Oct94, Vol. 62 Issue 10, p15 

    Reports on a study conducted by D. Krahn and colleagues at the University of Toronto, which suggested that screening asymptomatic men for prostate cancer lengthens their life expectancy by only a matter of days and may therefore be not worth the effort. Comparison of four standard screening...

  • PSA screening is highly sensitive in detecting aggressive prostate cancer but does it lower...  // Modern Medicine;Mar95, Vol. 63 Issue 3, p6 

    Reports on the confirmation of the validity of prostate-specific antigen (PSA) testing for detecting prostate cancer by Harvard Medical School and Harvard School of Public Health researchers in Boston, Massachusetts. Sensitivity and specificity; Reduction of mortality by PSA screening; Rate of...

  • PSA screening for prostate cancer: Which tests work, which don't.  // Modern Medicine;Aug95, Vol. 63 Issue 8, p41 

    Presents an abstract of the study titled `How to use prostate-specific antigen in the early detection or screening for prostatic carcinoma,' by M.K. Brawer, published in the May/June 1995 issue of the `CA Cancer J. Clin.'

  • Doppler ultrasound may aid biopsy when you suspect prostate cancer.  // Modern Medicine;Aug95, Vol. 63 Issue 8, p42 

    Presents an abstract of the study titled `Prostate cancer: Diagnosis with color Doppler sonography with historic correlation of each biopsy site,' by J.S. Newman, R.L. Bree, et al, published in the April 1995 issue of `Radiology.'


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics